Merck & Company, Inc.: dividend
Price
$147.76
November 13, 2026Market cap $365B
What Ploutos Investor adds for Merck & Company
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Yield
2.30%
$3.40 per share over the last 12 months, at a price of $147.76.
Forward yield2.30%($0.85 a quarter)
- FCF coverThe year's free cash flow was 1.8 times the dividend it paid.
- 1.8x
- PayoutEarnings over the last twelve months are close to zero, so the dividend is a multiple of them and the exact percentage adds nothing.
- > 300%
- No cutWithout a cut since 2009, the first year of our figures: the run may be longer.
- 16+
- 5-year growthAverage yearly growth over the last five years.
- +5.8%
- Debt / EBITDAMoney that goes to interest does not go to the dividend.
- 5.7x
The dividend year by year
What it paid per share each fiscal year, how much that changed, and the yield it gave at the price at year end.
- 2025Dividend per share$3.28
- 2024Dividend per share$3.12
- 2023Dividend per share$2.96
| Year | Dividend per share | Change | Price | Yield then | As % of earnings |
|---|---|---|---|---|---|
| 2025 | $3.28 | +5.1% | $105.26 | 3.12% | 45% |
| 2024 | $3.12 | +5.4% | $99.48 | 3.14% | 46% |
| 2023 | $2.96 | – | $109.02 | 2.72% | > 300% |
Each fiscal year's dividend as the company states it in its filings, adjusted for stock splits. Special dividends count in the year they were paid.
The dividend year by year
MRK's dividend per share each fiscal year, from 2009 to 2022, 14 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
Everything it returns to shareholders
The dividend is one way. The other is buybacks, which reduce the number of shares.
Dividend yield
2.30%
$23.00 a year per $1,000 of shares
Buybacks
1.39%
$13.90 a year per $1,000 of shares
The share count fell by 2.1% over the year.
Total returned
3.69%
$36.90 a year per $1,000 of shares
dividend 62%buybacks 38%
MRK beside the other dividend payers
Where it stands among this week's 968 dividend payers, and in the Healthcare sector. The dot is the company, the white line the median.
Above 56% of the payers · median 2.03%
In Healthcare: above 81%, median 0.93%.
Above 23% of the payers · median 3.6x
In Healthcare: above 14%, median 4.4x.
Above 46% of the payers · median +6.3%
In Healthcare: above 45%, median +5.8%.
Among the highest on the list · median 35%
In Healthcare: above 98%, median 25%.
The full analysis
What do Merck & Company's filings show?
The dividend is one part of Merck & Company's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
What is MRK's dividend yield?
Merck & Company paid $3.40 per share over the last 12 months. At a price of $147.76, that is a yield of 2.30%.
Does MRK cover its dividend with the cash it makes?
Yes, over the last year. Merck & Company's free cash flow was 1.8 times the dividend it paid.
Has MRK ever cut its dividend?
Merck & Company has not cut its dividend for 16+ years, in the 17 years of figures we hold.
How much has MRK's dividend grown?
Merck & Company's dividend per share changed by +5.8% a year on average over the last five years.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.